NCT01285141View on ClinicalTrials.gov

Reactogenicity and Immunogenicity of Cervico-vaginal CN54gp140-hsp70 Conjugate Vaccine

PHASE1CompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

July 31, 2011

Primary Completion Date

January 31, 2012

Study Completion Date

December 31, 2012

Conditions
HIV Infections
Interventions
BIOLOGICAL

CN54gp140 glycoprotein-hsp70 conjugate vaccine

CN54gp140-hsp70 conjugate vaccine administered intravaginally 3 times over a 12-week period

Trial Locations (1)

SW17 0RE

St George's - University of London, London

All Listed Sponsors
collaborator

European Union

OTHER

lead

St George's, University of London

OTHER

NCT01285141 - Reactogenicity and Immunogenicity of Cervico-vaginal CN54gp140-hsp70 Conjugate Vaccine | Biotech Hunter | Biotech Hunter